Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.55 is 11% above its 5-year average of 7.68, around the middle of its 5-year range (5.29–10.25).
As of the fiscal period ended Tuesday, June 30, 2026. 31.97% above its 12-month average of 6.48.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.55.
CURRENT RATIO
8.55
CURRENT RATIO AVG TTM
6.48
CURRENT RATIO AVG 3Y
7.51
CURRENT RATIO AVG 5Y
7.68
CURRENT RATIO AVG 10Y
9.03
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+31.97%
CURRENT VS 3Y AVG
+13.79%
CURRENT VS 5Y AVG
+11.28%
CURRENT VS 10Y AVG
-5.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.58
median of 102 covered companies
CURRENT VS SECTOR MEDIAN
+439.49%
vs the sector median at left
Inspire Medical Systems, Inc.
Market Cap
$2.02B
Current Ratio
8.55
TTM Avg
6.48
3Y Avg
7.51
5Y Avg
7.68
Market Cap
$2.16B
Current Ratio
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$1.71B
Current Ratio
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | $2.02B | 8.55 | 6.48 | 7.51 | 7.68 |
| Fortrea Holdings Inc. (FTRE)vs › | $1.90B | 0.96 | 0.99 | 1.34 | 1.34 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | 5.03 | 4.66 | 4.92 | 7.11 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 1.63 | 1.31 | 1.40 | 1.40 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 6.65 | 5.42 | 7.28 | 7.47 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | 14.57 | 8.96 | 7.17 | 6.28 |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 6.62 | 7.72 | 8.85 | 8.81 |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | 0.83 | 2.23 | 2.80 | 3.02 |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | 3.60 | 3.12 | 4.79 | 5.52 |
| NRC Health (NRC)vs › | $458.62M | 0.65 | 0.55 | 0.77 | 1.10 |
Current Ratio
8.55
Quick Ratio
6.16
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.55 |
| 2026-03-31 | 6.34 |
| 2025-12-31 | 6.08 |
| 2025-09-30 | 5.29 |
| 2025-06-30 | 6.14 |
| 2025-03-31 | 9.01 |
| 2024-12-31 | 7.13 |
| 2024-09-30 | 7.84 |
| 2024-06-30 | 9.25 |
| 2024-03-31 | 7.93 |
| 2023-12-31 | 7.60 |
| 2023-09-30 | 8.14 |
| 2023-06-30 | 8.40 |
| 2023-03-31 | 8.91 |
| 2022-12-31 | 8.66 |
| 2022-09-30 | 10.05 |
| 2022-06-30 | 5.62 |
| 2022-03-31 | 6.08 |
| 2021-12-31 | 6.50 |
| 2021-09-30 | 7.61 |
| 2021-06-30 | 10.25 |
| 2021-03-31 | 13.43 |
| 2020-12-31 | 13.02 |
| 2020-09-30 | 14.67 |
| 2020-06-30 | 20.48 |
| 2020-03-31 | 11.33 |
| 2019-12-31 | 10.12 |
| 2019-09-30 | 13.42 |
| 2019-06-30 | 20.46 |
| 2019-03-31 | 24.09 |
| 2018-12-31 | 17.86 |
| 2018-09-30 | 17.11 |
| 2018-06-30 | 14.24 |
| 2018-03-31 | 3.40 |
| 2017-12-31 | 3.37 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
